Esorubicin in advanced endometrial cancer: an ineffective and potentially toxic therapy - A Southwest Oncology Group study

Jacob B. Green, Stephanie Green, Robert V. O'Toole, David S. Alberts, William A. Nahhas, Darryl L. Wallace

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Esorubicin in advanced endometrial cancer: an ineffective and potentially toxic therapy - A Southwest Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences